Psychiatric complications of disulfiram treatment
- 1 October 1987
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 144 (10) , 1310-1312
- https://doi.org/10.1176/ajp.144.10.1310
Abstract
The authors studied psychiatric complications of disulfiram use in 605 alcholic patients. The subjects were assigned to one of three treatment groups: a 250-mg disulfiram group (N = 202), a 1-mg disulfiram group (N = 204) to control for the fear of the alcohol-disulfiram reaction, and a no-disulfiram group (N = 199) to control for the effect of psychotherapy. No significant differences in the incidence of psychiatric complications were found among the three groups. The authors conclude that if psychiatric complications follow disulfiram use, the incidence must be very low with the doses of disulfiram used presently and in the absence of predisposing factors.This publication has 7 references indexed in Scilit:
- Disulfiram Treatment of AlcoholismJAMA, 1986
- Disulfiram encephalopathy as a cause of the catatonia syndromeAmerican Journal of Psychiatry, 1980
- Disulfiram toxicity and carbon disulfide poisoningAmerican Journal of Psychiatry, 1977
- Method for the detection of diethylamine, a metabolite of disulfiram, in urineJournal of Chromatography A, 1976
- Criteria for the Diagnosis of AlcoholismAnnals of Internal Medicine, 1972
- Disulfiram (Antabuse) PsychosisAmerican Journal of Psychiatry, 1967
- Inhibition of dopamine- β -hydroxylase by disulfiramLife Sciences, 1964